32 Firmen mit Ergebnissen für "limitations com"

ETH Entrepreneurship

https://ethz.ch/en/industry/entrepreneurship.html  

8952 Schlieren, Wagistrasse 18


 entrepreneurship@ethz.ch

Excellence in entrepreneurship at ETH Zurich is driven by world-​class research and education. It gives rise to groundbreaking new ventures that consolidate Switzerland’s technological leadership. Are you an aspiring entrepreneur seeking to find solutions to global challenges and create a better future for humanity. Or are you just interested in the entrepreneurial ecosystem at ETH Zurich? Browse our websites to find out more or reach out to the Entrepreneurship group, if you have any questions. 

ETH Entrepreneurship

Wagistrasse 18

8952 Schlieren

1758 Ergebnisse für "limitations com" unter ETH Entrepreneurship

Swiss Civilian Peace Support: Potential and Limitations

... Swiss Civilian Peace Support: Potential and Limitations CSS Analyses in Security Policy ETH Zurich ... CSS No. 63 • November 2009 SWISS CIVILIAN PEACE SUPPORT: POTENTIAL AND LIMITATIONS For several years ... Swiss Civilian Peace Support: Potential and Limitations ... Swiss Civilian Peace Support: Potential and Limitations CSS Analyses in Security Policy ETH Zurich ... Swiss Civilian Peace Support: Potential and Limitations ...

Cyberwar: Concept, Status Quo, and Limitations

... Cyberwar: Concept, Status Quo, and Limitations CSS Analysis in Security Policy ETH Zurich CSS No ... . 71 • April 2010 CYBERWAR: CONCEPT, STATUS QUO, AND LIMITATIONS Political, economic, and military ... Cyberwar: Concept, Status Quo, and Limitations ... Cyberwar: Concept, Status Quo, and Limitations CSS Analysis in Security Policy ETH Zurich CSS No ... Cyberwar: Concept, Status Quo, and Limitations ...

Mehr Ergebnisse

Somagenetix

https://www.wysszurich.ch/projects/somagenetix  

8952 Schlieren, Wagistrasse 23

Gene therapy solutions for patients with severe inherited diseases.

Somagenetix

Wagistrasse 23

8952 Schlieren

1680 Ergebnisse für "limitations com" unter Somagenetix

Editorial: Stressors in animals and humans - Practical issues and l...

... Editorial: Stressors in animals and humans - Practical issues and limitations Zurich Open ... www.zora.uzh.ch Year: 2017 Editorial: Stressors in animals and humans : Practical issues and limitations Pryce ... Editorial: Stressors in animals and humans - Practical issues and limitations ... Editorial: Stressors in animals and humans - Practical issues and limitations Zurich Open ... Editorial: Stressors in animals and humans - Practical issues and limitations ...

Detailed simulation of cancer exome sequencing data reveals differe...

... Detailed simulation of cancer exome sequencing data reveals differences and common limitations of ... reveals differences and common limitations of variant callers Hofmann, Ariane L ; Behr, Jonas ; Singer ... Detailed simulation of cancer exome sequencing data reveals differences and common limitations of ... Detailed simulation of cancer exome sequencing data reveals differences and common limitations of ... Detailed simulation of cancer exome sequencing data reveals differences and common limitations of ...

Mehr Ergebnisse

University of Zurich

https://www.campus-schlieren.uzh.ch/en.html  

8952 Schlieren, Wagistrasse 12

The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.

University of Zurich

Wagistrasse 12

8952 Schlieren

951 Ergebnisse für "limitations com" unter University of Zurich

UZH - FINEXUS: Center for Financial Networks and Sustainability - P...

... make by knowing the whole set of contracts, with some small limitations. It turns out that the small ... the financial market. However, in this article we show that there are intrinsic limitations in the ... Com ... small limitations. It turns out that the small errors on most of the relevant parameters can easily lead ... Com ...

Opportunities and limitations related to the application of plant-d...

... Jansen, Boris ; Wiesenberg, Guido L B (2017). Opportunities and limitations related to the ... a high diversity of input pathways offering both opportunities and limitations for the use of ... Opportunities and limitations related to the application of plant-derived lipid molecular proxies ... Opportunities and limitations related to the application of plant-derived lipid molecular proxies ... Opportunities and limitations related to the application of plant-derived lipid molecular proxies ...

Mehr Ergebnisse

CSL Vifor

https://www.csl.com/we-are-csl/our-businesses-and-products/csl-vifor  

8952 Schlieren, Zürcherstrasse 39D

 +41 58 851 80 00

Pioneer in iron-based therapies, CSL Vifor is a global leader in iron deficiency and iron deficiency anaemia therapies, with a history dating back to 1872, when pharmacist Caspar Friedrich Hausmann opened a pharmacy in St. Gallen, Switzerland. Since then, we have proven our ability to identify and serve therapeutic areas and patients with significant unmet medical need. Building on our heritage and expertise in iron deficiency therapy, and together with our joint company Vifor Fresenius Medical Care Renal Pharma, today we have a strong and rapidly growing presence in nephrology, and we are committed to launching the next generation of therapies to truly address the full spectrum of kidney disease.

CSL Vifor

Zürcherstrasse 39D

8952 Schlieren

14 Ergebnisse für "limitations com" unter CSL Vifor

CSL Seqirus Begins Shipping Portfolio of Innovative Influenza Vacci...

... children ages 1 to 17 years of age.10 Limitations of these studies include small sample sizes from a single ... additional information on influenza vaccine options for the upcoming flu season, visit flu360. com. About ... % effective at preventing symptomatic flu among children ages 1 to 17 years of age. 10 Limitations of these ... influenza vaccine options for the upcoming flu season, visit flu360. com. About Seasonal Influenza Influenza ...

PowerPoint Presentation

... outlines their proposal. Online submission of abstracts will open in January 2024. LIMITATIONS ON ABSTRACT ... outlines their proposal. Online submission of abstracts will open in January 2024. LIMITATIONS ON ABSTRACT ...

Mehr Ergebnisse

Blutspende SRK Zürich

https://www.blutspendezuerich.ch/  

8952 Schlieren, Rütistrasse 19

 +41 58 272 52 52
 info@zhbsd.ch

The Zurich Blood Transfusion Service SRK (ZHBSD) is a nonprofit foundation and independent partner in the healthcare sector. It ensures the supply of blood and blood products to patients in the Zurich region. Our products are made exclusively from voluntary, unpaid blood donations. We offer our services at cost-covering prices and without government subsidies. Along with ten other regional blood donation services in Switzerland, we are a member of the Swiss Red Cross Blood Donation Service (BSD SRK AG).

Blutspende SRK Zürich

Rütistrasse 19

8952 Schlieren

79 Ergebnisse für "limitations com" unter Blutspende SRK Zürich

... explained by a prolonged placebo effect and altered patient behavior.24 Limitations of this study are as ... did not result in a delay regarding surgical treatment for OA, com- pared with placebo. The findings ... explained by a prolonged placebo effect and altered patient behavior.24 Limitations of this study are as ... did not result in a delay regarding surgical treatment for OA, com- pared with placebo. The findings ...

Clinical Impact of Amotosalen-UVA Pathogen Inactivated Platelets St...

... Service, Basel, com- menced manufacture of all PCs with the INTERCEPT Blood System for Platelets in ... PI-PCs were more likely to be recipient ABO compatible (74.4% vs. 67.2% ABO com- patible; p < 0.001 ... Service, Basel, com- menced manufacture of all PCs with the INTERCEPT Blood System for Platelets in ... PI-PCs were more likely to be recipient ABO compatible (74.4% vs. 67.2% ABO com- patible; p < 0.001 ...

Mehr Ergebnisse

University Hospital Zurich​, Research and Education Office

https://www.usz.ch/forschung/Seiten/default.aspx  

8091 Zürich, Rämistrasse 100

The University Hospital Zurich is one of Switzerland’s largest hospitals and a pioneering institution in the field of clinical research. In its 40 departments and institutes, it assembles and practices all medical disciplines and enjoys an excellent reputation for state-of-the-art medicine, professional and com- passionate patient care, and groundbreaking bench-to-bedside translational medical research.

University Hospital Zurich​, Research and Education Office

Rämistrasse 100

8091 Zürich

69 Ergebnisse für "limitations com" unter University Hospital Zurich​, Research and Education Office

Myocardial triglycerides in cardiac amyloidosis assessed by proton ...

... accordance to the declaration of Helsinki and its later amendments. Local ethics com- mittee approval was ... strain rate = 1.5 ± 0.3 vs. 1.2 ± 0.2 s− 1, p = 0.06) with no statistical significance com- pared to the ... accordance to the declaration of Helsinki and its later amendments. Local ethics com- mittee approval was ... strain rate = 1.5 ± 0.3 vs. 1.2 ± 0.2 s− 1, p = 0.06) with no statistical significance com- pared to the ...

... evaluations of safety and effectiveness and for other issues, such as treatment com- pliance and disease risk ... limitations of the data which can be considered with regard to study design, data analysis, and finally the ... evaluations of safety and effectiveness and for other issues, such as treatment com- pliance and disease risk ... limitations of the data which can be considered with regard to study design, data analysis, and finally the ...

Mehr Ergebnisse

SecureCell AG

http://www.securecell.ch/  

8902 Urdorf, In der Luberzen 29

 +41 44 732 91 00
 contact@securecell.ch

Securecell is pioneering the world’s next solutions for global biotech and MedTech systems. From automated bioprocessing and smart pharmacological facilities to the transformative applications of digital technologies to help hospitals and life scientists solve next-world problems. At Securecell we believe the best future should be our next future, hence our technologies represent innovative solutions that can improve lives on a global scale.

SecureCell AG

In der Luberzen 29

8902 Urdorf

9 Ergebnisse für "limitations com" unter SecureCell AG

Securecell

... overcome the significant limitations of current solutions and better meet medical needs.       Contact us ... /; accessed Dec 15, 2021 9 https://www.bdtype1. com/difference-stable-type-1-vs-brittle, accessed Dec 20, 2021 ...

... in com- bination with small reactors starting at 0.25 L working volume and allows high- frequency ... preparation Significant and reliable data with Swiss precision technology All active and passive com- ponents ... in com- bination with small reactors starting at 0.25 L working volume and allows high- frequency ... preparation Significant and reliable data with Swiss precision technology All active and passive com- ponents ...

Mehr Ergebnisse

Zentrum für Kardiovaskuläre Genetik und Gendiagnostik c/o Stiftung für Menschen mit seltenen Krankheiten

http://www.genetikzentrum.ch/  

8952 Schlieren, Wagistrasse 25

 +41 43 433 86 86
 sekretariat@genetikzentrum.ch

Das Zentrum für Kardiovaskuläre Genetik und Gendiagnostik ist schweizweit das erste und einzige Zentrum, welches auf die molekulare Gendiagnostik und die Erforschung genetisch bedingter Aortenkrankheiten und deren klinische Konsequenzen, wie Aneurysmen und Dissektionen, spezialisiert ist.

Zentrum für Kardiovaskuläre Genetik und Gendiagnostik c/o Stiftung für Menschen mit seltenen Krankheiten

Wagistrasse 25

8952 Schlieren

2 Ergebnisse für "limitations com" unter Zentrum für Kardiovaskuläre Genetik und Gendiagnostik c/o Stiftung für Menschen mit seltenen Krankheiten

... regions. However, capturing has limitations in sufficiently covering coding exons, especially GC-rich ... regions. Materials and Methods: We com- pared whole exome sequencing (WES, SureSelect Human All Exon v5 ... regions. However, capturing has limitations in sufficiently covering coding exons, especially GC-rich ... regions. Materials and Methods: We com- pared whole exome sequencing (WES, SureSelect Human All Exon v5 ...

Recommendations for reporting of secondary findings in clinical exo...

... nomination form to collect all relevant informa- tion, SFWG members and colleagues were requested to com ... economic implications of these trends are broad, and it will be important for the genomics com- munity to ... nomination form to collect all relevant informa- tion, SFWG members and colleagues were requested to com ... economic implications of these trends are broad, and it will be important for the genomics com- munity to ...

Virometix AG

http://virometix.com  

8952 Schlieren, Wagistrasse 14

 +41 (0)43 433 86 60
 info@virometix.com

Virometix AG is a privately held biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic human diseases.

Virometix AG

Wagistrasse 14

8952 Schlieren

1 Ergebnisse für "limitations com" unter Virometix AG

Newsroom - Virometix AG

... , pave the way for the development of a novel vaccine that could address the limitations of current ... August – 02 September 2022; https://www.eps2022. com/ ). With presentations on our T-cell epitope SARS-CoV ...

CUTISS AG

http://cutiss.swiss  

8952 Schlieren, Grabenstrasse 11

 +41 44 244 36 60
 info@cutiss.swiss

After more than 15 years of research (Tissue Biology Research Unit, University Children’s Hospital Zurich), CUTISS AG can now bio-engineer large quantities of individually customized human skin grafts, denovoSkin™, starting off from a very small piece of healthy patient’s skin. Because of its intrinsic characteristics, denovoSkin™ is expected to result in a minimally scarring outcome after transplantation. denovoSkin™ received a Swissmedic, EMA and FDA Orphan drug designation for the treatment of burns.

CUTISS AG

Grabenstrasse 11

8952 Schlieren

17 Ergebnisse für "limitations com" unter CUTISS AG

Long-Term Outcomes of a Cultured Autologous Dermo-Epidermal Skin Su...

... , keratinocytes are seeded onto the surface of the graft to form the epidermal com- partment. After additional ... clinical trials. A number of limitations must be addressed. denovoSkin lacks 2 important anatomical and ... , keratinocytes are seeded onto the surface of the graft to form the epidermal com- partment. After additional ... clinical trials. A number of limitations must be addressed. denovoSkin lacks 2 important anatomical and ...

... generation skin grafts. Zurich, Switzerland, June 20th 2018 – CUTISS AG, a biotech com- pany spin-off of the ... generation skin grafts. Zurich, Switzerland, June 20th 2018 – CUTISS AG, a biotech com- pany spin-off of the ...

Mehr Ergebnisse

Mehr Firmen

Nach oben